NCT01769040View on ClinicalTrials.gov

Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Liver CirrhosisAscites
Interventions
DRUG

Rifaximin

550 mg two times daily for 28 days

DRUG

placebo

Trial Locations (1)

2650

Copenhagen University hospital Hvidovre, Hvidovre

Sponsors

Collaborators (1)

Norgine
All Listed Sponsors
collaborator

Norgine

INDUSTRY

collaborator

Region MidtJylland Denmark

OTHER

collaborator

Statens Serum Institut

OTHER

lead

Copenhagen University Hospital, Hvidovre

OTHER